Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC in the Treatment of Bleeding Episodes in Patients With Hemophilia A With Inhibitors
NCT07406139Phase 4Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of prothrombin complex concentrate, human in hemophilia A, sponsored by Institute of Hematology and Blood Diseases Hospital. Started Mar 2026; status: recruiting.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT07406139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07406139.